ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Piramal Pharma completes stake sale to Carlyle
October 10, 2020Piramal Enterprises subsidiary Piramal Pharma has concluded the previously announced sale of its 20% stake to US-based global investment firm Carlyle Group in a deal valued approximately Rs35.234bn ($480m). -
Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m
July 01, 2020US private equity firm Carlyle Group has agreed to acquire a stake of 20% stake in Piramal Pharma, the pharmaceutical business of Indian conglomerate Piramal Enterprises, in a deal worth up to $490m. -
Carlyle Group to acquire 20 per cent stake in Piramal Pharma
June 28, 2020The transaction worth $490 million is expected to close in 2020, subject to customary closing conditions and regulatory approvals.
Pharma Sources Insight January 2025
